(Atriance is registered trademarks Novartis Pharmaceuticals)
What is ATRIANCE:
Atriance is a medicine that contains the active substance Nelarabine and is available as a Vial.
Generic Name: Nelarabine
Strength: 250 mg/50 mL (5 mg/mL)
Company: Novartis Pharmaceuticals
Packing: Pack of 6 vials.
In how many countries ATIRANCE is approved for marketing:
Atrinace is available/approved in USA and Europe. We can help you to access it in India.
What is ATRIANCE used for:
Atriance is indicated for the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.
How can I get ATRIANCE in India?
ATRIANCE is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
• Helping in documentation to import the medicine for personal use
• Finding Genuine and reliable source in USA, Europe and Japan
• Ensuring 100% transparency.
ATIRNACE can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of ATIRNACE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get ATRIANCE even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing ATIRNACE, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your inquiry to find-
ATRIANCE in South East Asia – China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ATRIANCE in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ATRIANCE in North America – Mexico.
ATRIANCE in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ATRIANCE in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ATRIANCE in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ATRIANCE in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ATRIANCE in Australia and New Zealand.
How is ATRIANCE used?
ATRIANCE should be administered under the guidance of specialist doctor having experience in managing cancer treatments.
• Adult dose: 1,500 mg/m² administered intravenously over 2 hours on days 1, 3, and 5 repeated every 21 days.
• Pediatric dose: 650 mg/m² administered intravenously over 1 hour daily for 5 consecutive days repeated every 21 days.
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information
Are there any side-effects/ adverse reactions/precautions associated with treatment with ATRIANCE?
It is recommended to seek your doctor’s medical advice about side effects
How do I contact The Indian Pharma?
You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to firstname.lastname@example.org. We will respond within 24 hours after receiving your mail. Please mention detailed inquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.
What information do you need to help patient in assisting documentation for ATRIANCE import for personal use?
We will require the following documents to help in documentation for Named-Patient import
- Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
- Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
- Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.